Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · IEX Real-Time Price · USD
12.64
+0.75 (6.31%)
At close: Jul 19, 2024, 4:00 PM
12.80
+0.16 (1.27%)
Pre-market: Jul 22, 2024, 7:01 AM EDT
Perspective Therapeutics Revenue
Perspective Therapeutics had revenue of $-304.00K in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $325.00K with 39.48% year-over-year growth. In the year 2023, Perspective Therapeutics had annual revenue of $1.43M.
Revenue (ttm)
$-304.00K
Revenue Growth
-96.23%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
119
Market Cap
852.32M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.43M | - | - |
Jun 30, 2022 | 0 | - | - |
Jun 30, 2021 | 10.05M | 373.00K | 3.85% |
Jun 30, 2020 | 9.68M | 2.37M | 32.35% |
Jun 30, 2019 | 7.31M | 1.39M | 23.48% |
Jun 30, 2018 | 5.92M | 1.16M | 24.41% |
Jun 30, 2017 | 4.76M | -8.00K | -0.17% |
Jun 30, 2016 | 4.77M | 163.00K | 3.54% |
Jun 30, 2015 | 4.61M | 386.84K | 9.17% |
Jun 30, 2014 | 4.22M | -306.08K | -6.76% |
Jun 30, 2013 | 4.53M | -545.86K | -10.76% |
Jun 30, 2012 | 5.07M | -167.89K | -3.20% |
Jun 30, 2011 | 5.24M | -47.11K | -0.89% |
Jun 30, 2010 | 5.29M | -131.73K | -2.43% |
Jun 30, 2009 | 5.42M | -1.74M | -24.32% |
Jun 30, 2008 | 7.16M | 1.42M | 24.76% |
Jun 30, 2007 | 5.74M | 3.74M | 187.72% |
Jun 30, 2006 | 1.99M | 1.79M | 888.60% |
Jun 30, 2005 | 201.73K | - | - |
Sep 30, 2004 | 0 | - | - |
Sep 30, 2003 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Healthcare Services Group | 1.68B |
InnovAge Holding | 741.33M |
Pacira BioSciences | 681.75M |
GeneDx Holdings | 221.85M |
Harrow Health | 138.68M |
Cronos Group | 93.03M |
AbCellera Biologics | 35.79M |
Liquidia | 15.97M |
CATX News
- 1 hour ago - Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Perspective Therapeutics Announces Inclusion in the Russell 3000® Index - GlobeNewsWire
- 5 weeks ago - Perspective Therapeutics Announces 1-for-10 Reverse Stock Split - GlobeNewsWire
- 5 weeks ago - Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting - GlobeNewsWire
- 2 months ago - Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024 - GlobeNewsWire
- 2 months ago - Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results - GlobeNewsWire
- 2 months ago - Perspective Therapeutics to Participate at Upcoming May Investor Conferences - GlobeNewsWire